002620.KS
Jeil Pharma Holdings Inc
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,780.00
−1.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.33x
- PEG TTM
- 2.41x
- Price / book
- 0.34x
- Price / sales
- 0.17x
- Price / cash flow
- 9.13x
Enterprise value
- Enterprise value
- KRW 361.7B
- EV / sales
- 0.58x
- EV / EBITDA
- -9.22x
- EV / EBIT
- -86.57x
- Market cap
- KRW 108.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026